Help

MLC is developing its own high-tech continuous glucose monitoring (CGM) system. This device allows real-time blood glucose monitoring without painful finger pricks. The product is designed for the mass market, from people with diabetes to anyone actively monitoring their health, including athletes, children, and pregnant women.

CGM (Continuous Glucose Monitoring) is a device that measures glucose levels in a person's interstitial fluid 24/7.

The system consists of a sensor installed on the body, a reader (e.g., a smartphone or other connected device), and software for analyzing and displaying data.

CGM allows you to:

• monitor glucose levels in real time,
• warn about risks (hypo- or hyperglycemia),
• make timely decisions about your diet, physical activity, and medications.

MegaResearch carried out a study of the global CGM market and its prospects, commissioned by MLC. According to the report, with the current market size of $ 10.95 billion (2024) and enormous untapped potential (sales represent only 0.5% of the potential), the industry is poised for explosive growth. With annual growth forecasts of 15% to 30%, the market could grow 21-fold by 2045, amounting to $ 233 billion.

1. The prototype (industrial sample) is ready now. It is currently at the final stages of internal testing and debugging. Simultaneously, we have initiated the process of obtaining CE certification for the device.

2. Production is scheduled to begin in 2025, following successful completion of testing. The first step will be the production of a limited test batch of 10,000 devices by our first contract manufacturing line in China.

3. The first devices will not be commercially available. They will be used for:

• Final industrial certification.
• Field testing in actual operating conditions.
• Demonstration of the device's capabilities to potential partners and investors.

CGM is a solution for anyone who takes control of their health.

For people with diabetes, it means freedom and safety. The system eliminates painful injections and provides a dynamic picture, not just a single point.

For their families, it means peace of mind, especially when it comes to children or elderly relatives.

For doctors, it means objective data for making accurate clinical decisions.

For biohackers and athletes, it's a tool for optimizing energy, performance, and metabolic health.

Thus, the CGM market extends far beyond insulin-dependent patients, encompassing anyone interested in a deeper understanding of their body's functioning.

CGM Fly: 3 key differences

Convenience: Just a smartphone. No extra devices.

Intelligence: Integrated AI assistant provides personalized recommendations, not just graphs.

Comfort: The sensor is noticeably smaller than similar devices, so you barely feel it.

And this isn't a concept: we're already gearing up for global distribution.

The sensor's price will be close to the market price of similar products and will also vary depending on the country of distribution.

The goal is to make the product affordable even to low-income countries and ensure mass use without compromising quality.

The sensor transmits data via Bluetooth or NFC directly to a smartphone app (Android/iOS), and in the future, to smartwatches or other wearable devices.

A separate receiver is not required, making the system more convenient, portable, and cost-effective to use.

One sensor is designed to last approximately 14 days of continuous operation.

This is the standard service life for CGM devices, ensuring measurement accuracy and safety.
After its expiration, the sensor can be easily replaced with a new one.

Easy installation: An automatic applicator places the sensor on your forearm in seconds. It's painless and doesn't require a doctor's assistance.

Complete freedom: You can swim, exercise, and maintain an active lifestyle without feeling restricted.

1.Sign an agreement on the platform
You need to sign an investment agreement on the my.MLC.health platform. This is the foundation for further steps.
2. Purchase packages of investment shares in your personal office account
After signing the agreement, you can select and pay for the package of investment shares. The investment shares will be immediately credited to your personal office account electronically.
3. Get a certificate if necessary
You can generate a certificate at any time, that is an official statement confirming your right to the purchased investment shares.

By purchasing investment shares, you join the investment offering for the first contract manufacturing line in China and get:

Project investor status

Digital asset assigned to you in your personal office account.

Potential growth in the value of investment shares as the project develops.

Dividends that will be paid from the profits after launching the production facility and product sales.

Potential future sale of investment shares on the domestic or international market (after launching secondary circulation).

The investment amount is up to the user starting at $ 100 at this stage. Moreover, a 20-month installment plan with a $ 50 monthly payment is available for users.

The average amount of investment in the project from private individuals is $ 3,000.

The total budget for the implementation of the first contract manufacturing line for CGM Fly in China is up to $ 40 million.

The project is divided into several key stages:

PreSeed (until 2025): technology development, patents, and prototypes.

Seed (2025): preparation for production, bringing in investments, and launching the platform.

Production stage (2025–2026): producing the first test batch of CGM Fly.

Scaling (2026–2030): ramping up volumes, market entry, international distribution, and capitalization growth.

The first devices will hit the market in 2026, and by 2030, production is planned at up to 40 million units per year

Dividend payments will begin after the product sales start, approximately at the end of 2026.

Technology dividends: holders of technology investment shares will get up to 100% of the royalties paid by manufacturing companies for their use.
Royalty amounts: $ 3 to $ 5 per device produced. Dividends will be paid quarterly.

Production line dividends: holders of investment shares in the first production line in China will get up to 50% of the manufacturing company's net profit. Dividends will be calculated annually based on the year-end financial performance.

Go to the registration form on the MLC.health website or get the link from the person who told you about the project.

Use the Forgot Your Password? option. In the field that appears, enter the email address you registered your personal office account with. An email containing a link will be sent to the email address you provided. When you click the link, you will need to enter a new password.

Official website of the company: https://mlc.health
Facebook: https://www.facebook.com/mlc.health.official
Telegram: https://t.me/MLC_health_channel_en
YouTube: https://www.youtube.com/@en_mlc
Instagram: https://www.instagram.com/mlc_health_official
Twitter: https://twitter.com/MLC_Health

Your installment plan expires after 20 days. We recommend topping up your account in advance and setting up automatic debits.
Timely installment payments are rewarded with additional bonus investment shares.

Minimum package starts from $ 100. You can find the price list in the "Investment" section.

You can use bank cards issued in Europe, as well as in CIS countries.
The available payment methods are displayed in the personal office.
The methods differ depending on the country of residence.

The official website: https://mlc.health

You can find the schedule of all upcoming webinars in the "Events" section.